# Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations

> **NCT06041009** · — · RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 2100 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma
- Pancreatic Diseases
- Pancreatic Elastase 1
- Pancreatic Neuroendocrine Tumor
- Pancreatitis
- Pancreatic Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** Pancreatic elastase-1 in blood serum

## Key facts

- **NCT ID:** NCT06041009
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-05
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2024-10-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06041009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06041009, "Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06041009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*